NO20022202L - 5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasöytiske preparater inneholdende disse - Google Patents

5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasöytiske preparater inneholdende disse

Info

Publication number
NO20022202L
NO20022202L NO20022202A NO20022202A NO20022202L NO 20022202 L NO20022202 L NO 20022202L NO 20022202 A NO20022202 A NO 20022202A NO 20022202 A NO20022202 A NO 20022202A NO 20022202 L NO20022202 L NO 20022202L
Authority
NO
Norway
Prior art keywords
inhibitors
aryl
cyclooxygenase
pharmaceutical preparations
preparations containing
Prior art date
Application number
NO20022202A
Other languages
English (en)
Other versions
NO20022202D0 (no
NO328008B1 (no
Inventor
Jean-Claude Pascal
Denis Carniato
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO20022202D0 publication Critical patent/NO20022202D0/no
Publication of NO20022202L publication Critical patent/NO20022202L/no
Publication of NO328008B1 publication Critical patent/NO328008B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022202A 1999-11-09 2002-05-08 5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasoytiske preparater inneholdende disse, samt anvendelse derav NO328008B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99402784A EP1099695A1 (en) 1999-11-09 1999-11-09 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
PCT/EP2000/010956 WO2001034577A1 (en) 1999-11-09 2000-11-06 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO20022202D0 NO20022202D0 (no) 2002-05-08
NO20022202L true NO20022202L (no) 2002-05-08
NO328008B1 NO328008B1 (no) 2009-11-09

Family

ID=8242172

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022202A NO328008B1 (no) 1999-11-09 2002-05-08 5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasoytiske preparater inneholdende disse, samt anvendelse derav

Country Status (24)

Country Link
US (1) US6803380B1 (no)
EP (2) EP1099695A1 (no)
JP (1) JP4786846B2 (no)
CN (1) CN1198807C (no)
AT (1) ATE245148T1 (no)
AU (1) AU778819B2 (no)
BR (1) BR0015440A (no)
CA (1) CA2390649C (no)
CZ (1) CZ20021591A3 (no)
DE (1) DE60003949T2 (no)
DK (1) DK1246809T3 (no)
ES (1) ES2203538T3 (no)
HU (1) HUP0203376A3 (no)
IL (2) IL149370A0 (no)
MX (1) MXPA01012903A (no)
NO (1) NO328008B1 (no)
NZ (1) NZ518682A (no)
PL (1) PL204230B1 (no)
PT (1) PT1246809E (no)
RU (1) RU2249588C2 (no)
SI (1) SI1246809T1 (no)
TW (1) TWI268925B (no)
WO (1) WO2001034577A1 (no)
ZA (1) ZA200203165B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390181A1 (en) * 2001-07-05 2003-01-05 Andrei Shavnya Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents
ATE297913T1 (de) 2001-07-05 2005-07-15 Pfizer Prod Inc Sulfonyl-heteroaryl-triazole als entzündungshemmende und analgetische mittel
ES2241964T3 (es) 2001-07-05 2005-11-01 Pfizer Products Inc. Heterocicloalquilsulfufonilpirazoles como agentes antiinflamatorios/abnalgesicos.
KR100824233B1 (ko) 2001-10-10 2008-04-24 씨제이제일제당 (주) 사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난3,4-디하이드로-1ｈ-나프탈렌 유도체
WO2003037336A1 (en) 2001-11-02 2003-05-08 Pfizer Products Inc. 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
AUPR878201A0 (en) 2001-11-09 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. New compounds
KR100686537B1 (ko) 2001-12-28 2007-02-27 씨제이 주식회사 사이클로옥시게나제-2 의 저해제로서 선택성이 뛰어난디아릴 1,2,4-트리아졸 유도체
US6797722B2 (en) * 2002-05-03 2004-09-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
KR100467668B1 (ko) * 2002-08-07 2005-01-24 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100470075B1 (ko) * 2002-11-21 2005-02-05 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100491317B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100470076B1 (ko) * 2002-11-27 2005-02-05 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
WO2004060367A1 (en) * 2002-12-30 2004-07-22 Fujisawa Pharmaceutical Co., Ltd. Imidazole and triazole derivatives useful as selective cox-1 inhibitors
KR101402633B1 (ko) * 2005-04-28 2014-06-03 시바 홀딩 인크 전기발광 장치
WO2008017932A2 (en) * 2006-08-09 2008-02-14 Pfizer Products Inc. Heterocycles useful as inhibitors of carbonic anhydrase
WO2012070596A1 (en) * 2010-11-26 2012-05-31 Semiconductor Energy Laboratory Co., Ltd. Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device
WO2012170839A2 (en) * 2011-06-09 2012-12-13 Cardeus Pharmaceuticals, Inc. Treatment of neuroinflammatory disease with selective cox1 inhibitors
US8853248B2 (en) * 2012-04-05 2014-10-07 Hubert Maehr (1,2,3-triazolyl)sulfonyl derivatives
CN104693133A (zh) * 2015-02-16 2015-06-10 广州市盈宇医药科技有限公司 一种环氧化酶-2选择性抑制剂及其制备方法和应用
AU2019229521A1 (en) 2018-03-08 2020-09-03 Bayer Aktiengesellschaft Use of heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides in plant protection
MX2020010671A (es) 2018-04-12 2020-10-28 Bayer Ag Derivados de n-(ciclopropilmetil)-5-(metilsulfonil)-n-11-[1-(pirim idin-2-il)-1h-1,2,4-triazol-5-il] etilibenzamida y los derivados de piridinacarboxamida correspondientes como plaguicidas.
SG11202010068VA (en) 2018-04-25 2020-11-27 Bayer Ag Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides
CA3148216A1 (en) 2019-07-23 2021-01-28 Bayer Aktiengesellschaft Novel heteroaryl-triazole compounds as pesticides
AU2020318590A1 (en) 2019-07-23 2022-02-17 Bayer Aktiengesellschaft Novel heteroaryl-triazole compounds as pesticides
BR112022006791A2 (pt) 2019-10-09 2022-06-28 Bayer Ag Novos compostos heteroaril-triazol como pesticidas
TW202134226A (zh) 2019-11-18 2021-09-16 德商拜耳廠股份有限公司 作為殺蟲劑之新穎雜芳基-三唑化合物
BR112022016400A2 (pt) 2020-02-18 2022-10-25 Bayer Ag Compostos inovadores de heteroaril-triazol como pesticidas
TWI754474B (zh) * 2020-11-30 2022-02-01 翁豐富 具選擇性第二型環氧合酶抑制活性之1,2,4-三氮唑衍生物及其用途
CN112480073B (zh) * 2020-12-02 2022-03-22 武汉药明康德新药开发有限公司 1-烷基-3,5-芳基取代的1,2,4三氮唑化合物的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW226993B (no) * 1992-05-29 1994-07-21 Kumiai Chemical Industry Co
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
JPH0776577A (ja) * 1993-07-14 1995-03-20 Kumiai Chem Ind Co Ltd ジフェニルトリアゾール誘導体及び殺虫、殺ダニ剤
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation

Also Published As

Publication number Publication date
NO20022202D0 (no) 2002-05-08
CN1198807C (zh) 2005-04-27
DE60003949T2 (de) 2004-05-27
PL356120A1 (en) 2004-06-14
ATE245148T1 (de) 2003-08-15
AU778819B2 (en) 2004-12-23
NO328008B1 (no) 2009-11-09
CA2390649C (en) 2008-05-06
IL149370A0 (en) 2002-11-10
IL149370A (en) 2007-06-17
RU2249588C2 (ru) 2005-04-10
ES2203538T3 (es) 2004-04-16
HUP0203376A2 (hu) 2003-01-28
NZ518682A (en) 2003-07-25
JP4786846B2 (ja) 2011-10-05
DE60003949D1 (de) 2003-08-21
CA2390649A1 (en) 2001-05-17
ZA200203165B (en) 2003-06-25
DK1246809T3 (da) 2003-10-20
HUP0203376A3 (en) 2004-12-28
TWI268925B (en) 2006-12-21
US6803380B1 (en) 2004-10-12
PL204230B1 (pl) 2009-12-31
EP1246809A1 (en) 2002-10-09
EP1099695A1 (en) 2001-05-16
EP1246809B1 (en) 2003-07-16
AU1998501A (en) 2001-06-06
PT1246809E (pt) 2003-11-28
BR0015440A (pt) 2002-07-02
WO2001034577A1 (en) 2001-05-17
CZ20021591A3 (cs) 2002-07-17
SI1246809T1 (en) 2004-02-29
MXPA01012903A (es) 2002-11-07
CN1387517A (zh) 2002-12-25
JP2003513961A (ja) 2003-04-15

Similar Documents

Publication Publication Date Title
NO20022202L (no) 5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasöytiske preparater inneholdende disse
DK0911333T3 (da) Pyrazol [4,3-d]pyrimidinderivater og farmaceutiske præparater, der indeholder disse
MXPA03004549A (es) Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
IS6658A (is) Ný efnasambönd
WO2002048147A3 (en) Pyrazolopyridines
NO20020925L (no) N-heterosykliske derivater av NOS-inhibitorer
ATE316083T1 (de) Adamantanderivate
NO20024614L (no) N-heterosykliske derivater som NOS-hemmere
NO20052794L (no) Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse
WO2002048148A3 (en) Pyrazolopyridine derivatives
ATE353216T1 (de) 1-substituierten imidazol derivaten als nos inhibitoren
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
WO2003097597A3 (fr) Derives d'indole et leur utilisation en tant que ligands des recepteurs cb2
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
NO20044466L (no) Plasma-karboksypeptidase B-inhibitorer
ATE274515T1 (de) Pyrazolopyridinderivate
SE9904128D0 (sv) Novel compounds
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
DK1245565T3 (da) Indenoindolon-forbindelse, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1387837T3 (da) Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler
DK1387841T3 (da) Hidtil ukendt azol- eller triazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som fungicider
WO2004093796A3 (en) Lactam derivatives and methods of their use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees